Vetoquinol S.A. is a leading pharmaceutical company specializing in veterinary medicine and animal health. Operating primarily within the veterinary pharmaceutical sector, Vetoquinol develops, manufac... Vetoquinol S.A. is a leading pharmaceutical company specializing in veterinary medicine and animal health. Operating primarily within the veterinary pharmaceutical sector, Vetoquinol develops, manufactures, and markets a wide range of products designed to improve the health and well-being of both companion and livestock animals. The company's portfolio includes antibiotics, anti-inflammatory drugs, and other health supplements, addressing critical needs in the veterinary field.
With a global presence, Vetoquinol plays a vital role in the agriculture and pet care industries by ensuring that veterinarians and animal owners have access to high-quality and effective medical solutions. The company’s commitment to research and innovation drives its ability to meet the evolving demands of the animal health market.
Vetoquinol's contributions not only support the health of animals but also have significant implications for public health, food safety, and sustainable livestock practices. As a family-owned company founded in 1933 and headquartered in Lure, France, Vetoquinol continues to uphold its tradition of excellence and integrity in the veterinary pharmaceutical industry, cementing its status as a key player in the market.
Pending data availability
Financial Fundamentals Data missing for Vetoquinol
We haven’t collected Financial Fundamentals data for Vetoquinol yet, or the company
hasn’t made it publicly available.